Advocacy in the Treatment Era

As science transforms dementia from untreatable to treatable, advocacy needs to evolve — to drive implementation, shape policy, and foster the collaborations needed to deliver real change. With new diagnostics and treatments emerging, the question is no longer if progress is possible, but whether systems and advocates are ready to deliver it. In partnership with Alzheimer's Association the World Dementia Council hosted a breakfast on Wednesday 30 July at AAIC that asked where now for advocacy? 

This meeting served as the starting point for a new programme of work by the World Dementia Council that will explore how to accelerate collaboration and build partnerships across the global advocacy movement in an era of treatments. 

This is an invitation only meeting. For more information email info@worlddementiacouncil.com 

  • Read the agenda

    The breakfast discussion, on where now for advocacy, is chaired by Dr Joanne Pike, President and CEO of Alzheimer's Association and Chair of World Dementia Council. There will be opening contributions from Lenny Shallcross, Dr Rebecca Edelmayer, Professor Donna Wilcocks, Robert Egge, Dr Fiona Carragher and Professor Lea Grinberg. The opening contriutions will be followed by a roundtable discussion for all particpants at the breakfast meeting.  

  • Advancing Advocacy

    The latest blog from World Dementia Council Executive Director Lenny Shallcross argues that science has brought the global dementia movement to a turning point, with disease-modifying treatments and advances in diagnosis offering new hope and urgency. As innovation accelerates, he highlights that public policy will determine whether these breakthroughs deliver real-world impact. His blog calls for a renewed, broad-based advocacy coalition to drive action — from research labs to patient organizations.